Mechanisms of Photosensitization to Drugs in Humans

  • L. C. Harber
  • I. E. Kochevar
  • A. R. Shalita
Part of the Photobiology book series (PB)


Drug-induced photosensitivity refers to adverse cutaneous reactions that result from either combined or successive exposure to certain chemicals and light. Although the word “drug” is properly used in reference to chemicals administered for therapeutic purposes, with regard to “drug-induced photosensitivity,” this term has been expanded to include chemicals used for various other purposes, such as sweeteners (1), topical antibacterial agents (2), perfumes (3), and industrial (4), and agricultural (5) products.


Systemic Lupus Erythematosus Porphyria Cutanea Tarda Phototoxic Reaction Variegate Porphyria Erythropoietic Protoporphyria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lamberg, S. I. (1967): A new photosensitizer, the artificial sweetner cyclamate. J. AMA 201:747–750.Google Scholar
  2. 2.
    Wilkinson, D. S. (1961): Photodermatitisdue to tetrachlorosalicylanilide. Br. J. Dermatol. 73:213–219.PubMedCrossRefGoogle Scholar
  3. 3.
    Harber, L. C., Harris, H., Leider, M., et al. (1964): Berloque (berlock) dermatitis. Arch. Dermatol. 90:572–576.PubMedCrossRefGoogle Scholar
  4. 4.
    Crow, K. D., Alexander, E., Buck, W. H. L., et al. (1961): Photosensitivitydueto pitch Br. J. Dermatol. 73:220–232.PubMedCrossRefGoogle Scholar
  5. 5.
    Birmingham, D. J., Key, M. M., Tubich, G. E., et al. (1961): Phototoxicbullaeamongcelery harvesters. Arch. Dermatol. 83:73–87.CrossRefGoogle Scholar
  6. 6.
    Raab, O. (1900): Über die Wirkung fluorescierender Stoffe auf Infusorien. Z. Biol. 39:524.Google Scholar
  7. 7.
    Tappeiner, H. V., and Jodlbauer, A. (1904): Die sensibilizierende Wirkungfluroescierender Substanzer. Dtsch. Arch. Klin. Med. 80:524.Google Scholar
  8. 8.
    Blum, H. F. (1941): Photodynamic Action and Diseases Caused by Light. Reinhold, New York.Google Scholar
  9. 9.
    Oginsky, E. L., Green, G. S., Griffith, D. G., et al. (1959): Lethal photosensitization of bacteria with 8-methoxypsoralen to long wavelength ultraviolet radiation. J. Bacteriol 78:821–833.PubMedGoogle Scholar
  10. 10.
    Mathews, M. M. (1963): Comparative study of lethal photosensitization of Sarcina lutea by 8-methoxypsoralen and by toluidine blue. J. Baeteriol. 85:322–328.Google Scholar
  11. 11.
    Pathak, M. A., Kramer, D. M., and Fitzpatrick, T. B. (1974): Photobiology and photochemistry of furocoumarins (psoralens). In: Sunlight and Man: Normal and Abnormal Photobiologic Responses, edited by M. A. Pathak, L. C. Harber, M. Seiji, et al., pp. 131–141. Univ. of Tokyo Press, Tokyo.Google Scholar
  12. 12.
    Blum, H. F. (1964): Photodynamic Action and Diseases Caused by Light. Hofner, New York.Google Scholar
  13. 13.
    Epstein, S. (1939): Photoallergy and primary photosensitivity to sulfanilamide. J. Invest. Dermatol. 2:43–51.CrossRefGoogle Scholar
  14. 14.
    Peterkin, G. A. (1945): Skin eruptions due to the local application of sulphonamides. Br. J. Dermatol. 57:1–9.CrossRefGoogle Scholar
  15. 15.
    Magnus, I. A. (1976): Dermatological Photobiology, pp. 213–217. Blackwell, London.Google Scholar
  16. 16.
    Forbes, P. D., Urbach, F., and Davies, R. E. (1978): Phototoxicity testing of fragrance raw materials, Fd. Cosmet. Toxicol. 15:55–60.CrossRefGoogle Scholar
  17. 17.
    Emmett, E. A. (1979): Phototoxicity from exogenous agents. Photochem. Photobiol. 30:429–436.PubMedCrossRefGoogle Scholar
  18. 18.
    Hjorth, N., and Moeller, H. (1976): Phototoxic textile dermatitis. Arch. Dermatol. 112:1445–1447.PubMedCrossRefGoogle Scholar
  19. 19.
    Gardiner, J. D., Dicksen, A., MacLeod, T. M., et al. (1972): The investigation of photocontact dermatitis in a dye manufacturing process. Br. J. Dermatol. 86:264–271.PubMedCrossRefGoogle Scholar
  20. 20.
    Sams, W. M., Jr., and Epstein, J. H. (1967): The experimental production of drug phototoxicity in guinea pigs. I. Using sunlight. J. Invest. Dermatol. 48:89–94.PubMedGoogle Scholar
  21. 21.
    Epstein, J. H., Brunsting, L. A., Peterson, M. C., et al. (1957): Study of photosensitivity occurring with chlorpromazine therapy. J. Invest. Dermatol. 28:329–338.PubMedGoogle Scholar
  22. 22.
    Epstein, S. (1968): Chlorpromazine photosensitivity: phototoxic and photoallergic reactions. Arch. Dermatol. 98:354–363.PubMedCrossRefGoogle Scholar
  23. 23.
    Foerster, H. R., and Schwartz, L. (1939): Industrial dermatitis and melanosis due to photosensitization. Arch. Dermatol. 39:55–68.CrossRefGoogle Scholar
  24. 24.
    Ramsay, C. A., and Obreshkova, E. (1974): Photosensitivity from nalidixic acid. Br. J. Dermatol. 91:523–528.PubMedCrossRefGoogle Scholar
  25. 25.
    De Eds, F., Wilson, R. H., and Thomas, J. O. (1940): Photosensitization by phenothiazene. J. AMA 114:2095–2097.Google Scholar
  26. 26.
    Morris, W. E. (1960): Photosensitivity due to tetracycline derivatives. J. AMA 172:1155–1156Google Scholar
  27. 27.
    Falk, M. S. (1960): Light sensitivity due to demethylchlortetracycline. J. AMA 172:1156–1157Google Scholar
  28. 28.
    Harber, L. C., Tromovitsh, T. A., and Baer, R. L. (1961): Studiesonphotosensitivitydueto demethylchlortetracycline. J. Invest. Dermatol. 37:189–193.PubMedGoogle Scholar
  29. 29.
    Domonkos, A. N. (1975): Andrew’s Diseases of the Skin, Chap. 3, pg. 40. W. B. Saunders, Philadelphia.Google Scholar
  30. 30.
    Lerner, A. B., Denton, C. R., and Fitzpatrick, T. B. (1953): Clinical and experimental studies with 8-methoxypsoralen in vitiligo. J. Invest. Dermatol. 20:299–314.PubMedGoogle Scholar
  31. 31.
    Kaidbey, K. H., and Kligman, A. M. (1974): Topical photosensitizers. Influence of vehicles on penetration. Arch. Dermatol. 110:868–870.PubMedCrossRefGoogle Scholar
  32. 32.
    Freeman, R. G., and Knox, J. M. (1964): Influence of temperature on ultraviolet injury. Arch. Dermatol. 89:858–864.PubMedCrossRefGoogle Scholar
  33. 33.
    Levine, G. M., and Harber, L. C. (1969): The effect of humidity on the phototoxic response to 8-methoxypsoralen in guinea pigs. Acta Derm. Venereol. (Stockh.) 49:82–86.Google Scholar
  34. 34.
    Harber, L. C., and Baer, R. L. (1972): Pathogenic mechanisms of drug-induced photosensitivity. J. Invest. Dermatol 58:327–342.PubMedCrossRefGoogle Scholar
  35. 35.
    Breza, T. S., Halprin, K. M., and Taylor, J. R. (1975): Photosensitivity to vinblastine. Arch. Dermatol. 111:1168–1170.PubMedCrossRefGoogle Scholar
  36. 36.
    Allison, A. C., Magnus, I. A., and Young, M. R. (1966): Role of lysosomes and of cell membrane in photosensitization. Nature 209:874–878.PubMedCrossRefGoogle Scholar
  37. 37.
    Giese, A., and Grossman, E. B. (1946): Sensitization of cells to heat by visible light in the presence of photodynamic dyes. J. Gen. Physiol. 29:193–202.CrossRefGoogle Scholar
  38. 38.
    Fleischer, A. S., Harber, L. C., Cook, J. S., et al. (1966): Mechanisms of in vitro photohemolysis in erythropoietic protoporphyria. J. Invest. Dermatol. 46:505–509.Google Scholar
  39. 39.
    Masajo, L., Rodighiero, G., Caporale, G., et al. (1974): Photoreactions between skinphotosensitizing furocourmarins and nucleic acids. In: Sunlight and Man: Normal and Abnormal Photobiologic Responses, edited by M. A. Pathak, L. C. Harber, M. Seiji, et al., pp. 369–387. Univ. of Tokyo Press, Tokyo.Google Scholar
  40. 40.
    Ljunggren, B. (1977): Phenothiazine phototoxicity: toxic chlorpromazine photoproducts. J. Invest. Dermatol. 69:383–386.PubMedCrossRefGoogle Scholar
  41. 41.
    Kochevar, I. E. (1980): Possible mechanisms of toxicity due to photochemical products of protriptyline. Toxicol. Appl. Pharmacol 54:258–264.PubMedCrossRefGoogle Scholar
  42. 42.
    Foote, C. S. (1976): Photosensitized oxidation and singlet oxygen: consequences in biological systems. In: Free Radicals in Biology, edited by W. A. Pryor, pp. 85–134. Academic Press, New York.Google Scholar
  43. 43.
    Lamola, A. A., Yamane, T., and Trozzolo, A. M. (1973): Cholesterol hyproperoxide formation in red cell membranes and photohemolysis in erythropoietic protoporphyria. Science 1979:1131–1133.Google Scholar
  44. 44.
    Lochmann, E. R., and Micheler, A. (1973): Bindingof organic dyes to nucleic acids and the photodynamic effect. In: Physicochemical Properties of Nucleic Acids, edited by J. Duchesne, Vol. I, pp. 223–267. Academic Press, New York.Google Scholar
  45. 45.
    Spikes, J. D., and MacKnight, M. L. (1970): Dye sensitized photooxidation of proteins. Ann. N.Y. Acad. Sci. 171:149–162.CrossRefGoogle Scholar
  46. 46.
    Girotti, A. (1975); Photodynamic action of bilirubin in human erythrocyte membranes. Biochemistry 14:3377–3383.PubMedCrossRefGoogle Scholar
  47. 47.
    Hsu, J., Goldstein, B. D., and Harber, L. C. (1971): Photoreactions associated with in vitro hemolysis in erythropoietic protoporphyria. Photochem. Photobiol. 13:67–77.PubMedCrossRefGoogle Scholar
  48. 48.
    Johnson, B. (1974): Cellular mechanisms of chlorpromazine photosensitivity. Proe. R. Soc. Med. 67:871–873.Google Scholar
  49. 49.
    Kochevar, I. E., and Lamola, A. A. (1979): Chlorpromazine and protriptyline phototoxicity: photosensitized, oxygen independent red cell lysis. Photochem. Photobiol. 29:791–796.PubMedCrossRefGoogle Scholar
  50. 50.
    Goldstein, B. D., and Harber, L. C. (1972): Erythropoietic protoporphyria: lipid peroxidation and red cell membrane damage associated with photohemolysis. J. Clin. Invest. 51:892–902.PubMedCrossRefGoogle Scholar
  51. 51.
    Schothorst, A. A., van Steveninck, J., Went, L. N., et al. (1972): Photodynamic damage of the erythrocyte membrane caused by protoporphyrin in protoporphyria and in normal red blood cells. Clin. Chim. Acta 39:161–170.PubMedCrossRefGoogle Scholar
  52. 52.
    Dubbelman, T. M. A. R., de Goeij, A. F. P. M., and van Steveninck, J. (1980): Protoporphyrin-induced photodynamic effects on transport processes across the membrane of human erythrocytes. Biochim. Biophys. Acta 595:133–139.PubMedCrossRefGoogle Scholar
  53. 53.
    Girotti, A. (1979): Protoporphyrin-sensitized photodamage in isolater membranes of human erythrocytes. Biochemistry 18:4403–4411.PubMedCrossRefGoogle Scholar
  54. 54.
    Desai, I. D., Savant, P. L., and Tappel, A. L. (1964): Peroxidation and radiation damage to isolated lysosomes. Biochim. Biophys. Acta 86:277–285.PubMedCrossRefGoogle Scholar
  55. 55.
    Song, P. -S., and Tapley, K. J., Jr. (1979): Photochemistryand photobiology of psoralens. Photochem. Photobiol. 29:1177–1197.PubMedCrossRefGoogle Scholar
  56. 56.
    Cole, R. S., Levithan, D., and Sinden, R. R. (1976): Removal of psoralen interstrand cross-links from DNA of Escherichia coli: mechanism and genetic control. J. Mol. Biol. 103:39–59.PubMedCrossRefGoogle Scholar
  57. 57.
    Poppe, W., and Grossweiner, L. I. (1979): Photodynamie sensitization by 8-methoxy-psoralen via the singlet oxygen mechanism. Photochem. Photobiol. 22:217–219.CrossRefGoogle Scholar
  58. 58.
    Goyal, G. C., and Grossweiner, L. I. (1979): The effect of DNA binding on initial 8-methoxypsoralen photochemistry. Photochem. Photobiol. 29:847–850.PubMedCrossRefGoogle Scholar
  59. 59.
    Satanove, A., and Mcintosh, J. S. (1967): Phototoxic reactions induced by light doses of chlorpromazine and thoridazine. J. AMA 200:121–124.Google Scholar
  60. 60.
    Kaidbey, K. H., and Kligman, A. M. (1978): Identification of systemic phototoxic drugs by human intradermal assay. J. Invest. Dermatol. 70:272–274.PubMedCrossRefGoogle Scholar
  61. 61.
    Schultz, K. H., Wiskemann, A., and Wulf, K. (1956): Klinische und experimentelle Untersuchungen über die photodynamische Worksamkeit von Phenotheizinderivaten, insbesundere von Megaphen. Arch. Klin. Exp. Dermatol. 202:285–298.Google Scholar
  62. 62.
    Hunder, J. A. A., Blutani, L. K., and Magnus, I. A. (1970): Chlorpromazine photosensitivity in mice: its action specrum and the effect of anti-inflammatory agents. Br. J. Dermatol. 82:157.CrossRefGoogle Scholar
  63. 63.
    Ljunggren, B., and Moeller, H. (1977): Phenathiazine phototoxicity: an experimental study in chlorpromazine and its metabolites. J. Invest. Dermatol. 68:313–317.PubMedCrossRefGoogle Scholar
  64. 64.
    Kelly-Garvert, F., and Legator, M. S. (1973): Photoactivation of chlorpromazine: cytogenetic and mutagenic effects. Mutat. Res. 21:101–105.PubMedCrossRefGoogle Scholar
  65. 65.
    Jose, J. G. (1979): Photomutagenesis by chlorinated phenathiazine tranquilizers. Proc. Natl. Acad. Sci. U.S.A. 76:469–472.PubMedCrossRefGoogle Scholar
  66. 66.
    Starples, D. (1974): The binding of chlorpromazine to human serum albumin. J. Pharm. Pharmacol. 26:640–641.CrossRefGoogle Scholar
  67. 67.
    Kantesaria, P., and Marfey, P. (1975): The effect of chlorpromazine in some properties of DNA in solution. Physiol. Chem. Phys. 7:53–67.PubMedGoogle Scholar
  68. 68.
    Kwant, W. O., and Suman, P. (1969): The membrane concentration of a local anasthetic (chlorpromazine). Biochim. Biophys. Acta 183:530–543.PubMedCrossRefGoogle Scholar
  69. 69.
    Kahn, G., and Davis, B. P. (1970): In vitro studies on long wavelength ultraviolet light-dependent reactions of the skin photosensitizer chlorpromazine with nucleic acids, purines and pyrimidines. J. Invest. Dermatol. 55:47–52.PubMedCrossRefGoogle Scholar
  70. 70.
    Rosenthal, I., Ben-hur, E., Prager, A., et al. (1978): Photochemical reactions to chlorpromazine: chemical and biochemical implication. Photochem. Photobiol. 28:591–594.PubMedCrossRefGoogle Scholar
  71. 71.
    Day, R. S., and Dimattina, M. (1977): Photodynamie action of chlorpromazine in adenovirus 5: repairable damage and single strand breaks. Chem. Biol. Interact. 17:89–97.PubMedCrossRefGoogle Scholar
  72. 72.
    Jose, J. G., and Yielding, K. L. (1978): Photosensitive cataractogens, chlorpromazine and methoxypsoralen, cause DNA repair synthesis in lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 17:687–691.PubMedGoogle Scholar
  73. 73.
    Matsuo, I., Ohkido, M., Fujita, H., et al. (1980): Chlorpromazine photosensitization: failure to detect any evidence for involvement of DNA damage in the photodynamie killing of Escherichia coli in the presence of chlorpromazine. Photochem. Photobiol. 31:175–178.CrossRefGoogle Scholar
  74. 74.
    Copeland, E. S., Alving, C. R., and Grenan, M. M. (1976): Light-induced leakage of spin label marker from liposomes in the presence of phototoxic phenothiazines. Photochem. Photobiol. 24:41–48.PubMedCrossRefGoogle Scholar
  75. 75.
    Kaidbey, K. H., and Kligman, A. M. (1977): Clinical and histological study of coal tar phototoxicity in humans. Arch. Dermatol. 113:592–595.PubMedCrossRefGoogle Scholar
  76. 76.
    Burckhardt, W. (1939): Zeer Frage der Photosensibilisierunden Wirkung des Teers. Schweiz. Med. Wochenschr. 69:83.Google Scholar
  77. 77.
    Foerster, H. R., and Schwartz, L. (1939): Industrial dermatitis and melanosis due to photosensitization. Arch. Dermatol. Syphilol 39:55–68.CrossRefGoogle Scholar
  78. 78.
    Everett, M. A., and Miller, J. V. (1961): Coaltarand ultraviolet light II. Cumulative effects. Arch. Dermatol. 84:937–940.PubMedCrossRefGoogle Scholar
  79. 79.
    Blackburn, G. M., and Fenwick, R. G., Lockwood, G., et al. (1977): Photoproducts from DNA pyrimidine bases and polycyclic aromatic hydrocarbons. Nucleic Acids Res. 4:2487–2494.PubMedCrossRefGoogle Scholar
  80. 80.
    Epstein, J. H., Tuffanelli, D. L., Seibut, J. S., et al. (1976): Porphyrialikecutaneouschanges induced by tetracycline hydrochloride photosensitization. Arch. Dermatol. 112:661–666.PubMedCrossRefGoogle Scholar
  81. 81.
    Stratigos, J. D., and Magnus, I. A. (1968): Photosensitivity by demethylchlortetracycline and sulfanilamide. Br. J. Dermatol. 80:391–405.PubMedCrossRefGoogle Scholar
  82. 82.
    Schorr, W. F., and Monash, S. (1963): Photo-irradiation studies of two tetracyclines. Arch. Dermatol. 88:440–443.PubMedCrossRefGoogle Scholar
  83. 83.
    Freeman, R. G. (1970): Interaction of phototoxic compounds with cells in tissue culture. Arch. Dermatol. 102:521–526.PubMedCrossRefGoogle Scholar
  84. 84.
    Schothorst, A. A., Suurmond, D., and de Luster, A. (1979): A biochemical screening test for the photosensitizing potential of drugs and disinfectants. Photochem. Photobiol. 29:531–537.PubMedCrossRefGoogle Scholar
  85. 85.
    Blum, H. F. (1941): Studies of photosensitivity due to sulfanilamide. J. Invest. Dermatol. 4:159–173.CrossRefGoogle Scholar
  86. 86.
    Aoki, K, and Saito, T. (1974): Studies in the mechanism of photosensitivity caused by sulfa drugs. In: Sunlight and Man: Normal and Abnormal Photobiologic Responses, edited by M. A. Pathak, L. C. Harber, M. Seiji, et al., pp. 431–444. Univ. of Tokyo Press, Tokyo.Google Scholar
  87. 87.
    Sam, S. K., and Tomlinson, D. R. (1976): Chlorpromazine-induced histamine release from guinea pig skin in vitro—a photosensitive reaction. Arch. Dermatol. Res. 255:219–223.CrossRefGoogle Scholar
  88. 88.
    Lord, J. T., Zeboh, V. A., Poitier, J., et al. (1976): The effects of photosensitizers and ultraviolet irradiation on the biosynthesis and metabolism of prostaglandins. Br. J. Dermatol. 95:397–406.PubMedCrossRefGoogle Scholar
  89. 89.
    Lord, J. T., Zeboh, V. A., Blick, G., et al. (1978): Theeffects of photosensitizing antibiotics and ultraviolet irradiation on the biosynthesis of prostaglandins. Br. J. Dermatol. 98:31–38.PubMedCrossRefGoogle Scholar
  90. 90.
    Warin, A. P. (1978): The ultraviolet erythemas in man. Br. J. Dermatol. 98:473–477.PubMedCrossRefGoogle Scholar
  91. 91.
    Morison, W. L., Paul, B. S., and Parrish, J. A. (1977): The effects of indomethacin on long-wave ultraviolet-induced delayed erythema. J. Invest. Dermatol. 68:130–133.PubMedCrossRefGoogle Scholar
  92. 92.
    Gschnait, F., and Pehamberger, H. (1977): Indomethacin does not affect PUVA induced erythema. Arch. Dermatol. Res. 259:109PubMedCrossRefGoogle Scholar
  93. 93.
    Epstein, J. H. (1972): Photoallergy. A review. Arch. Dermatol. 106:741–748.PubMedCrossRefGoogle Scholar
  94. 94.
    Morison, W. L., Parrish, J. A., and Epstein, J. H. (1979): Photoimmunology. Arch. Dermatol. 115:350–355.PubMedCrossRefGoogle Scholar
  95. 95.
    Wilkinson, D. S. (1961): Photodermatitisdue to tetrachlorosalicylanilide. Br. J. Dermatol. 73:213–219.PubMedCrossRefGoogle Scholar
  96. 96.
    Fregert, S, and Moller, H. (1964): Photocross-sensitization among halogenhydroxybenzoic acid derivatives. J. Invest. Dermatol. 43:271–274.PubMedGoogle Scholar
  97. 97.
    Schwarz, J, and Schwarz-Speck, M. (1957): Experimentelle Untersuchungen zur Frage der Photoallergie der Sulfonamide. Dermatologica 114:232–243.PubMedCrossRefGoogle Scholar
  98. 98.
    Vinson, L. J., and Borselli, V. F. (1966): Aguinea pig assay of the photosensitizing potential of topical germicides. J. Soc. Cosmet. Chem. 17:123–130.Google Scholar
  99. 99.
    Harber, L. C., Targovnik, S. E., and Baer, R. L. (1967): Contact photosensitivity to halogenated salicylanilides: in man and guinea pigs. Arch. Dermatol. 96:646–656.PubMedCrossRefGoogle Scholar
  100. 100.
    Schwartz, K. F. (1969): Experimentelle Unterschungen zur Photoallergic gegen Sulfanil-amid und Chlorpromazine. Dermatologica (Suppl.) 139:1–88.Google Scholar
  101. 101.
    Kochevar, I. E., Zalar, G. L., Einbinder, J., et al. (1979): Assayofcontactphotosensitivityto musk ambrette in guinea pigs. J. Invest. Dermatol 73:144–146.CrossRefGoogle Scholar
  102. 102.
    Willis, I., and Kligman, A. M. (1968): The mechanism of photoallergic contact dermatitis. J. Invest. Dermatol 51:378–384.PubMedGoogle Scholar
  103. 103.
    Mathias, C. G. B., Maicbac, H. I., and Epstein, J. (1978): Allergic contact Photodermatitis to para-aminobenzoic acid. Arch. Dermatol 114:1665–1666.PubMedCrossRefGoogle Scholar
  104. 104.
    O’Quinn, S., Kennedy, C. B., and Isbell, K. H. (1967): Contact Photodermatitis due to bithionol and related compounds. J. AMA 199:125–128.Google Scholar
  105. 105.
    Jillson, O. F., and Baughman, R. D. (1963): Contact Photodermatitis from bithionol. Arch. Dermatol. 88:409–418.PubMedCrossRefGoogle Scholar
  106. 106.
    Hitselberger, J. F., and Fosnaugh, R. P. (1962): Photosensitivity due to chlorpropamide. J. AMA 180:62–63.Google Scholar
  107. 107.
    Burry, J. M. (1967): Photoallergies to fentichlor and multifungin. Arch. Dermatol. 95:287–291.PubMedCrossRefGoogle Scholar
  108. 108.
    Morikawa, F., Nakayama, Y., Fukuda, M., et al. (1974): Techniques for evaluation of phototoxicity and photoallergy in laboratory animals and man. In: Sunlight and Man: Normal and Abnormal Photobiologic Responses, edited by M. A. Pathak, L. C. Harber, M. Seiji, et al., pp. 529–557. Univ. of Tokyo Press, Tokyo.Google Scholar
  109. 109.
    Kaidbey, K. H., and Kligman, A. M. (1978): Photocontact allergy to 6-methylcoumarin. Contact Derm. 4:277–282.PubMedCrossRefGoogle Scholar
  110. 110.
    Raugi, G. J., Storrs, F. S., and Larsen, W. G. (1979): Photoallergic contact dermatitis to men’s perfume. Contact Derm. 5:251–260.PubMedCrossRefGoogle Scholar
  111. 111.
    Sidi, E., Hincky, M., and Gervais, A. (1955): Allergic sensitization and photosensitization to Phenergan cream. J. Invest. Dermatol. 24:345–352.PubMedCrossRefGoogle Scholar
  112. 112.
    Harber, L. C., Lashinsky, A. M., and Baer, R. L. (1959): Skin manifestations of photosensitivity due to chlorothiazide and hydrochlorothiazide. J. Invest. Dermatol 33:83–84.PubMedCrossRefGoogle Scholar
  113. 113.
    Harber, L. C., Baer, R. L., and Bickers, D. R. (1974): Techniques of evaluation of phototoxicity and photoallergy in biologic systems, including man, with particular emphasis on immunologic aspects. In: Sunlight and Man: Normal and Abnormal Photobiologic Responses, edited by M. A. Pathak, L. C. Harber, M. Seiji, et al., pp. 515–528. Univ. of Tokyo Press, Tokyo.Google Scholar
  114. 114.
    Cripps, D. J., and Enta, T. (1970): Absorptionand action spectrum studies on bithionol and halogenated salicylanilide photosensitivity. Br. J. Dermatol 82:230–242.PubMedCrossRefGoogle Scholar
  115. 115.
    Freeman, R. G., and Knox, J. M. (1968): The action spectrum of photocontact dermatitis caused by halogenated salicylanilides and related compounds. Arch. Dermatol 97:130–136.PubMedCrossRefGoogle Scholar
  116. 116.
    Giovinazzo, V. J., Harber, L. C., Armstrong, R. B., et al. (1980): Photoallergic contact dermatitis to must ambrette: clinical report of two patients with persistent light reactor patterns. J. Am. Acad. Dermatol 3:384.PubMedCrossRefGoogle Scholar
  117. 117.
    Willis, I., and Kligman, A. M. (1968): The mechanism of the persistent light reactor. J. Invest. Dermatol 51:385–394.PubMedGoogle Scholar
  118. 118.
    Kochevar, I. E. (1979): Photoallergic responses to chemicals. Photochem. Photobiol 30:437–442.PubMedCrossRefGoogle Scholar
  119. 119.
    Harber, L. C., and Baer, R. L. (1969): Mechanisms of drug photosensitivity reactions. Toxicol Appl Pharmacol Suppl 3:58–67.CrossRefGoogle Scholar
  120. 120.
    Jung, E. G., Dummler, V., and Immich, H.(1968): Photoallergie durch 4-chlor-2-hydroxy-benzoesaure-H-butylamide II. Arch. Klin. Exp. Med. 232:403–412.Google Scholar
  121. 121.
    Herman, P. S., and Sams, W. M., Jr. (1970): Carrier protein specificity in salicylanilide sensitivity. J. Invest. Dermatol 54:438–439.Google Scholar
  122. 122.
    Herman, P. S., and Sams, W. M., Jr. (1971): Requirement for carrier protein in salicylanilide sensitivity: the migration inhibition test in contact photoallergy. J. Lab. Clin. Med. 77:572–579.PubMedGoogle Scholar
  123. 123.
    Kochevar, I. E., and Harber, L. C. (1977): Photoreactions of 3,3′,4′,5-tetrachloro-salicylanilide with proteins. J. Invest. Dermatol 68:151–156.PubMedCrossRefGoogle Scholar
  124. 124.
    Jung, E. G., Hornke, J., and Hajdu, P. (1968): Photoallergie durch 4-chlor-2-hydroxy-benzpesauer-N-butylamid. I. Arch. Klin. Exp. Dermatol 233:287–295.PubMedGoogle Scholar
  125. 125.
    Coxon, J. A., Jenkins, F. P., and Welti, D. (1965): The effect of light on halogenated salicylanilide ions. Photochem. Photobiol 4:713–718.CrossRefGoogle Scholar
  126. 126.
    Herman, P. S., and Sams, W. M., Jr. (1971): Requirement for carrier protein in salicylanilide sensitivity: the mitgration inhibition test in contact photoallergy. J. Lab. Clin. Med. 77:572–579.PubMedGoogle Scholar
  127. 127.
    DeMatteis, F. (1967): Disturbances of liver porphyrin metabolism caused by drugs. Pharmacol. Rev. 19:523–557.Google Scholar
  128. 128.
    Kappas, A., Song, C. S., Levere, R. D., et al. (1968): Induction of δ-aminolevulinic acid synthetase in vivo in chick embryo liver by natural steroids. Proc. Natl. Acad. Sci. U.S.A. 61:509–513.PubMedCrossRefGoogle Scholar
  129. 129.
    Stonard, M. D. (1974): Experimental hepatic porphyria induced by hexachlorobenzene as a model for human symptomatic porphyria. Br. J. Haematol. 27:617–625.PubMedCrossRefGoogle Scholar
  130. 130.
    Harber, L. C., and Bickers, D. R. (1975): The porphyrias: basic science aspects, clinical diagnosis and management. In: Yearbook of Dermatology, 1975, edited by F. D. Malkinson and R. W. Pearson, pp. 9–47. Year Book Publishers, Chicago.Google Scholar
  131. 131.
    Eales, L. (1963): Porphyria as seen in Cape Town: a survey of 250 patients and some recent studies. S. Afr. J. Lab. Clin. Med. 9:151–162.Google Scholar
  132. 132.
    Brunsting, L. A., Mason, H. L., and Aldrich, R. A. (1951): Adultformofchronicporphyria with cutaneous manifestations: report of 17 additional cases. J. AMA 146:1207–1212.Google Scholar
  133. 133.
    Watson, C. J. (1960): The problem of porphyria: some facts and questions. N. Engl. J. Med. 263:1205–1215.PubMedCrossRefGoogle Scholar
  134. 134.
    Watson, C. J., Lowry, P. T., Schmid, R., et al. (1951): Manifestation of different forms of porphyria in relation to chemical findings. Trans. Assoc. Am. Physicians 64:345–352.PubMedGoogle Scholar
  135. 135.
    Cam, C., and Nigogosyan, G. (1963): Acquired toxic porphyria cutanea tarda due to hexachlorobenzene intoxication. J. A MA 183:88–91.Google Scholar
  136. 136.
    Ockner, R. K., and Schmid, R. (1961): Acquired toxic porphyria cutanea tarda due to hexachlorobenzene. Nature 189:499.PubMedCrossRefGoogle Scholar
  137. 137.
    Bleiberg, J., Wallen, M., Brodkin, R., et al. (1964): Industriallyacquired prophyria. Arch. Dermatol. 89:793–797.PubMedCrossRefGoogle Scholar
  138. 138.
    Granick, S., and Urata, G. (1963): Increase in activity of delta-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3, 5-dicarbethozl-l,4-dihydrocollidine. J. Biol. Chem. 238:821–827.PubMedGoogle Scholar
  139. 139.
    Granick, S. (1966): The induction in vitro of the synthesis of H-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones and foreign chemicals. J. Biol. Chem. 241:1359–1375.PubMedGoogle Scholar
  140. 140.
    Rifkind, A. B., Gillette, P. N., Song, C. S., et al. (1970): Induction of hepatic 5-aminolevulinic acid synthetase by oral contraceptive steroids. J. Clin. Endocrinol. Metab. 30:330–335.PubMedCrossRefGoogle Scholar
  141. 141.
    Levere, R. D. (1967): Porphyrin synthesis in hepatic cirrhosis: increase in δ-aminolevulinic acid synthetase. Biochem. Med. 1:92–99.CrossRefGoogle Scholar
  142. 142.
    Levere, R. D. (1966): Stilbesterol-induced porphyria: increase in hepatic δ-aminolevulinic acid synthetase. Blood 28:569–572.PubMedGoogle Scholar
  143. 143.
    Zimmerman, T. S., McMillin, J. M., and Watson, C. J. (1966): Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch. Intern. Med. 118:229–240.PubMedCrossRefGoogle Scholar
  144. 144.
    Warin, R. P. (1963): Porphyriacutaneatardaassociated with estrogen therapy for prostatic carcinoma. Br. J. Dermatol. 75:298–299.PubMedGoogle Scholar
  145. 145.
    Felsher, B. F., Norris, M. E., and Shih, J. C. (1978): Red cell uroporphyrinogen decarboxylase in prophyria cutanea tarda. N. Engl. J. Med. 299:1095–1098.PubMedCrossRefGoogle Scholar
  146. 146.
    Granick, S., and Kappas, A. (1967): Steroid induction of prophyrin synthesis in liver cell culture I. J. Biol. Chem. 242:4587–4593.PubMedGoogle Scholar
  147. 147.
    Kappas, A., and Granick, S. (1968): Steroid induction of porphyrin synthesis in liver cell culture II. J. Biol. Chem. 243:346–351.PubMedGoogle Scholar
  148. 148.
    De Matteis, F. (1971): Drugsand porphyria. S. Afr. J. Lab. Clin. Med. 18:126–133.Google Scholar
  149. 149.
    Talbott, J. H. (1974): Collagen-Vascular Diseases. Grune & Stratton, New York.Google Scholar
  150. 150.
    Harber, L. C., and Baer, R. L. (1972): Pathogenic mechanisms of drug-induced photosensitivity. J. Invest. Dermatol. 58:327–342.PubMedCrossRefGoogle Scholar
  151. 151.
    Rodman, G. P. (ed.) (1973): Primer on the rheumatic diseases. J. AMA (Suppl) 224:701–805.Google Scholar
  152. 152.
    Tan, E. M. (1974): Drug-induced autoimmune disease. Fed. Proc. 33:1894–1897.PubMedGoogle Scholar
  153. 153.
    Bromgren, S. E., Condemi, J. J., and Vaughan, J. H. (1972): Procainamide-induced lupus erythematosus. Clinical and laboratory observations. Am. J. Med. 52:338–348.CrossRefGoogle Scholar
  154. 154.
    Baehr, G., Klemperer, P., and Schifien, A. (1935): A diffuse disease of the peripheral circulation. Trans. Assoc. Am. Physician 50:139–155.Google Scholar
  155. 155.
    McConnell, R. B., and Cheetham, H. D. (1952): Acute pellagra during isonazid therapy. Lancet 263:959–960.CrossRefGoogle Scholar
  156. 156.
    Goldberger, J., Waring, C. H., and Willets, H. D. (1915): The prevention of pellagra: a test diet among institutional inmates. Public Health Rep. 30:3117–3131.CrossRefGoogle Scholar
  157. 157.
    Harber, L. C., Baer, R. L., and Bickers, D. R. (1974): Photosensitization to drugs. Clinical features and mechanisms of action. In: Proceedings of the International Conference on Photosensitization and Photoprotection, pp. 211–220. Kanehara Shuppan, Tokyo.Google Scholar
  158. 158.
    Ludwig, G. D., and White, C. (1960): Pellagra induced by 6-mercaptopurine. Clin. Res. 8:212.Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • L. C. Harber
    • 1
  • I. E. Kochevar
    • 1
  • A. R. Shalita
    • 2
  1. 1.Department of DermatologyColumbia University College of Physicians and SurgeonsNew YorkUSA
  2. 2.Division of Dermatology, Department of MedicineState University of New York, Downstate Medical CenterBrooklynUSA

Personalised recommendations